Search for human DNA topoisomerase II poisons in the group of 2,5-disubstituted-1,3,4-thiadiazoles

References

• Cancer Facts & Figures 2014. American Cancer Society. Available from: http://www.cancer.org/acs/groups/content/@research/documents/webcontent/acspc-042151.pdf [last accessed 17 August 2014]
   Google Scholar
• Williams RJ, Walker I, Takle AK. Collaborative approaches to anticancer drug discovery and development: a Cancer Research UK perspective. Drug Discov Today 2012;17:185–7
   PubMed Web of Science ®Google Scholar
• Hu Y, Li CY, Wang XM, et al. 1,3,4-Thiadiazole: synthesis, reactions, and applications in medicinal, agricultural, and materials chemistry. Chem Rev 2014;114:5572–610
   PubMed Web of Science ®Google Scholar
• Jain AK, Sharma S, Vaidya A, et al. 1,3,4-Thiadiazole and its derivatives: a review on recent progress in biological activities. Chem Biol Drug Des 2013;81:557–76
   PubMed Web of Science ®Google Scholar
• Ibrahim DA. Synthesis and biological evaluation of 3,6-disubstituted [1,2,4]triazolo[3,4-b][1,3,4]thiadiazole derivatives as a novel class of potential anti-tumor agents. Eur J Med Chem 2009;44:2776–81
   PubMed Web of Science ®Google Scholar
• Radi M, Crespan E, Botta G, et al. Discovery and SAR of 1,3,4-thiadiazole derivatives as potent Abl tyrosine kinase inhibitors and cytodifferentiating agents. Bioorg Med Chem Lett 2008;18:1207–11
   PubMed Web of Science ®Google Scholar
• Chou JY, Lai SY, Pan SL, et al. Investigation of anticancer mechanism of thiadiazole-based compound in human non-small cell lung cancer A549 cells. Biochem Pharmacol 2003;66:115–24
   PubMed Web of Science ®Google Scholar
• Almajan GL, Innocenti A, Puccetti L, et al. Carbonic anhydrase inhibitors. Inhibition of the cytosolic and tumor-associated carbonic anhydrase isozymes I, II, and IX with a series of 1,3,4-thiadiazole- and 1,2,4-triazole-thiols. Bioorg Med Chem Lett 2005;15:2347–52
   PubMed Web of Science ®Google Scholar
• Gupta A, Singh P, Kamble B, et al. Synthesis, docking and biological evaluation of some novel 5-bromo-2-(5-aryl-1,3,4-thiadiazol-2-yl)isoindoline-1,3-dione derivatives targeting ATP-binding site of topoisomerase II. Lett Drug Des Discov 2012;9:668–75
   Web of Science ®Google Scholar
• Juszczak M, Matysiak J, Niewiadomy A, et al. The activity of a new 2-amino-1,3,4-thiadiazole derivative 4ClABT in cancer and normal cells. Folia Histochem Cytobiol 2011;49:436–44
   PubMed Web of Science ®Google Scholar
• Kellner U, Sehested M, Jensen PB, et al. Culprit and victim-DNA topoisomerase II. Lancet Oncol 2002;3:235–43
   PubMed Web of Science ®Google Scholar
• Larsen AK, Escarqueil AE, Skladanowski A. Catalytic topoisomerase II inhibitors in cancer therapy. Pharmacol Ther 2003;99:167–81
   PubMed Web of Science ®Google Scholar
• Huang KC, Gao H, Yamasaki EF, et al. Topoisomerase II poisoning by ICRF-193. J Biol Chem 2001;276:44488–94
   PubMed Web of Science ®Google Scholar
• Froelich-Ammon SJ, Osheroff N. Topoisomerase poisons: harnessing the dark side of enzyme mechanism. J Biol Chem 1995;270:21429–32
   PubMed Web of Science ®Google Scholar
• Chou JY, Lai SY, Pan SL, et al. Investigation of anticancer mechanism of thiadiazole-based compound in human non-small cell lung cancer A549 cells. Biochem Pharmacol 2003;66:115–24
   PubMed Web of Science ®Google Scholar
• Matysiak J, Opolski A. Synthesis and antiproliferative activity of N-substituted 2-amino-5-(2,4-dihydroxyphenyl)-1,3,4-thiadiazoles. Bioorg Med Chem 2006;14:4483–9
   PubMed Web of Science ®Google Scholar
• Matysiak J, Nasulewicz A, Pełczyńska M, et al. Synthesis and antiproliferative activity of some 5-substituted 2-(2,4-dihydroxyphenyl)-1,3,4-thiadiazoles. Eur J Med Chem 2006;41:475–82
   PubMed Web of Science ®Google Scholar
• Siwek A, Bielawska A, Maciorkowska E, et al. Cytotoxicity and topoisomerase I/II inhibition activity of novel 4-aryl/alkyl-1-(piperidin-4-yl)-carbonylthiosemicarbazides and 4-benzoylthiosemicarbazides. J Enzyme Inhib Med Chem 2014;29:243–8
   PubMed Web of Science ®Google Scholar
• Lepiarczyk M, Kałuża Z, Bielawska A, et al. Cytotoxic activity of octahydropyrazin[2,1-a:5,4-a′]diisoquinoline derivatives in human breast cancer cells. Arch Pharm Res 2014; DOI 10.1007/s12272-014-0444-z
   Google Scholar
• Kramer B, Rarey M, Lengauer T. Evaluation of the FlexX incremental construction algorithm for protein-ligand docking. Proteins 1999;37:228–41
   PubMed Web of Science ®Google Scholar
• LeadIT 2.1.0. BioSolveIT GmbH, St. Augustin, Germany, 2012
   Google Scholar
• Wu CC, Li TK, Farh L, et al. Structural basis of type II topoisomerase inhibition by the anticancer drug etoposide. Science 2011;333:459–62
   PubMed Web of Science ®Google Scholar
• Hyperchem 8.0.1. Gainsville (FL):HyperCube Inc.; 2007
   Google Scholar
• Becke AD. Density-functional thermochemistry. III. The role of exact exchange. J Chem Phys 1993;98:5648–52
   Web of Science ®Google Scholar
• Lee C, Yang W, Parr RG. Development of the Colle-Salvetti conelation energy formula into a functional of the electron density. Phys Rev B 1988;37:785–9
   PubMed Web of Science ®Google Scholar
• Ditchfield R, Hehre WJ, Pople JA. Self-consistent molecular-orbital methods. IX. An extended Gaussian-type basis for molecular-orbital studies of organic molecules. J Chem Phys 1971;54:724–8
   Web of Science ®Google Scholar
• Francl M, Pietro WJ, Hehre WJ, et al. Self-consistent molecular orbital methods. XXIII. A polarization-type basis set for second-row elements. J Chem Phys 1982;77:3654–65
   Web of Science ®Google Scholar
• Frisch MJ, Pople JA, Binkley JS. Self-consistent molecular orbital methods 25. Supplementary functions for Gaussian basis sets. J Chem Phys 1984;80:3265–9
   Web of Science ®Google Scholar
• Frisch MJ, Trucks GW, Schlegel HB, et al. Gaussian 09, Revision A.02. Wallingford (CT): Gaussian, Inc.; 2009
   Google Scholar
• Foster JP, Weinhold F. Natural hybrid orbitals. J Am Chem Soc 1980;102:7211–18
   Web of Science ®Google Scholar
• Frisch Æ, Hratchian HP, Dennington RD II, et al. GaussView 5. Wallingford (CT): Gaussian; 2009
   Google Scholar
• Carmichael J, Degraff W, Gazdar A, et al. Evaluation of a tetrazolinium-based semiautomated colorimetric assay: assessment of chemosensitivity testing. Cancer Res 1987;47:936–42
   PubMed Web of Science ®Google Scholar
• Data available at: http://www.topogen.com/drug-screening-kits/topoisomerase-ii-drug-screening-kit-kdna-based.html [last accessed 5 Sep 2014]
   Google Scholar